Literature DB >> 7231477

Quinidine-rifampin interaction.

Y Twum-Barima, S G Carruthers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7231477     DOI： 10.1056/NEJM198106113042405

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  Rifampicin lowers plasma concentrations of propafenone and its antiarrhythmic effect.

Authors:  J M Castel; E Cappiello; D Leopaldi; R Latini
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

2.  Possible implications of doxycycline-rifampin interaction for treatment of brucellosis.

Authors:  J D Colmenero; L C Fernández-Gallardo; J A Agúndez; J Sedeño; J Benítez; E Valverde
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

Review 3.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 4.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Impaired enzyme induction by rifampicin in the elderly.

Authors:  Y Twum-Barima; T Finnigan; A I Habash; R D Cape; S G Carruthers
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

Review 6.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

7.  Effect of rifampicin treatment on the kinetics of mexiletine.

Authors:  P J Pentikäinen; I H Koivula; H A Hiltunen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 8.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.

Authors:  S Wanwimolruk; W Kang; P F Coville; S Viriyayudhakorn; S Thitiarchakul
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

10.  Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.

Authors:  D J Edwards; J E Axelson; J P Visco; S vanEvery; R L Slaughter; D Lalka
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.